Minimally invasive management of primary bilateral macronodular adrenal hyperplasia (PBMAH): unilateral, bilateral adrenalectomy or sparing surgery debulking?

Authors

DOI:

https://doi.org/10.48193/evmgh238

Keywords:

Cushing syndrome, laparoscopic adrenalectomy, primary bilateral macronodular adrenal hyperplasia

Abstract

Clinical case: a 51-year-old female patient, with a history of controlled type 2 Diabetes mellitus, reported diaphoresis, headache, fine tremors of 6 months' duration, grade I obesity, stretch marks on the abdominal wall and cortisol of 1189 μg/dL. A CT scan showed an increase in the size of both adrenal glands. Patient with clinical data of Cushing's syndrome, it was decided to perform laparoscopic left adrenalectomy, without complications. During follow-up, there was a significant decrease in cortisol and she was asymptomatic with significant improvement.

Relevance: primary bilateral macronodular adrenal hyperplasia (PHAMBP) is a rare cause of Cushing's syndrome less than 2 % and is often diagnosed by bilateral adrenal incidentalomas with hypercortisolism. Characterized by bilateral benign adrenal macronodules larger than 1 cm responsible for elevated cortisol levels. In this report we describe a case of this condition undergoing unilateral laparoscopic adrenalectomy.

Clinical implications: the importance lies in a multidisciplinary approach to make a correct diagnosis, to avoid the progression of symptoms with the possibility of clinical and biochemical remission with adrenalectomy.

Conclusions: unilateral resection of the largest adrenal gland can result in clinical and biochemical remission in >90 % of cases, with laparoscopic adrenalectomy being the treatment of choice.

Author Biographies

  • José Luis Romero-Uribe , Secretaría de Salud, Hospital General de Culiacán, Sinaloa, México.

    Third-year resident of the Urology specialty at the General Hospital of Culiacan

    Presentation of poster management of adrenal tumors at the Congress of the American Confederation of Urology Chile 2023

  • Mauricio Chaidez-Mendivil, Secretaría de Salud, Hospital General de Culiacán, Sinaloa, México.
    121 / 5,000 Fourth year resident of the Urology specialty at the General Hospital of Culiacán Chief Resident of Urology    

     

  • Dr. Alberto Jorge Camacho Castro, Secretaría de Salud, Hospital General de Culiacán, Sinaloa, México.

    Specialist in urology at the Dr. Manuel Gea González General Hospital and subspecialty of oncological urology at the National Institute of Cancerology
    Associate of Oncological Urology at the General Hospital of Culiacán 
    He currently holds the position of coordinator of linkage and new members of the Mexican Society of Urology

References

Tang P, Zhang J, Peng S, Yan X, Wang Y, Wang S, et al. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations. BMC Endocrine Disorders. 2023;23: 77. https://doi.org/10.1186/s12902-023-01324-3.

Vassiliadi DA, Tsagarakis S. Diagnosis and management of primary bilateral macronodular adrenal hyperplasia. Endocrine-Related Cancer. 2019;26(10): R567–R581. https://doi.org/10.1530/ERC-19-0240.

Araujo-Castro M, Iturregui Guevara M, Calatayud Gutiérrez M, Parra Ramírez P, Gracia Gimeno P, Hanzu FA, et al. Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition. Endocrinologia, Diabetes Y Nutricion. 2020;67(6): 408–419. https://doi.org/10.1016/j.endinu.2020.03.002.

Di Dalmazi G, Reincke M. Adrenal Surgery for Cushing’s Syndrome. Endocrinology and Metabolism Clinics of North America. 2018;47(2): 385–394. https://doi.org/10.1016/j.ecl.2018.01.004.

Charchar HLS, Fragoso MCBV. An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH). Journal of the Endocrine Society. 2022;6(5): bvac041. https://doi.org/10.1210/jendso/bvac041.

Bourdeau I, El Ghorayeb N, Gagnon N, Lacroix A. MANAGEMENT OF ENDOCRINE DISEASE: Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. European Journal of Endocrinology. 2018;179(2): R57–R67. https://doi.org/10.1530/EJE-18-0296.

Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, et al. Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics. British Journal of Radiology. 2017;90(1079): 20170330. https://doi.org/10.1259/bjr.20170330.

Yu Z, Gao J, Sun F. The effect of unilateral adrenalectomy on patients with primary bilateral macronodular adrenal hyperplasia. Hormones (Athens, Greece). 2023;22(2): 235–242. https://doi.org/10.1007/s42000-023-00428-8.

Bouys L, Chiodini I, Arlt W, Reincke M, Bertherat J. Update on primary bilateral macronodular adrenal hyperplasia (PBMAH). Endocrine. 2021;71(3): 595–603. https://doi.org/10.1007/s12020-021-02645-w.

Chevalier B, Vantyghem MC, Espiard S. Bilateral Adrenal Hyperplasia: Pathogenesis and Treatment. Biomedicines. 2021;9(10): 1397. https://doi.org/10.3390/biomedicines9101397.

Yoshiaki Tanno F, Srougi V, Almeida MQ, Ide Yamauchi F, Morbeck Almeida Coelho F, Nishi MY, et al. A New Insight into the Surgical Treatment of Primary Macronodular Adrenal Hyperplasia. Journal of the Endocrine Society. 2020;4(8): bvaa083. https://doi.org/10.1210/jendso/bvaa083.

Downloads

Published

2025-03-19

Issue

Section

Clinical cases